Aviva’s MiMedx Group MDXG Stock Holding History

Aviva’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$456K	Buy	118,456 +22,965	+24%	+$83.8K	﹤0.01%	748
2026 Q1	$377K	Buy	95,491 +24,257	+34%	+$122K	﹤0.01%	811
2025 Q4	$482K	Buy	71,234 +3,211	+5%	+$22.5K	﹤0.01%	787
2025 Q3	$475K	Sell	68,023 -4,789	-7%	-$33.3K	﹤0.01%	780
2025 Q2	$445K	Sell	72,812 -4,348	-6%	-$28.9K	﹤0.01%	829
2025 Q1	$586K	Buy	77,160 +11,814	+18%	+$98.7K	﹤0.01%	729
2024 Q4	$629K	Sell	65,346 -36,633	-36%	-$285K	﹤0.01%	671
2024 Q3	$603K	Buy	101,979 +16,044	+19%	+$106K	﹤0.01%	787
2024 Q2	$596K	Buy	85,935 +58,987	+219%	+$415K	﹤0.01%	793
2024 Q1	$208K	Buy	+26,948	New	+$217K	﹤0.01%	946

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Aviva's MDXG Position: Q2 2026 in Review

Aviva increased its MiMedx Group (MDXG) stake by 24% in Q2 2026, buying an estimated $83.8K and bringing the position to 118,456 shares worth $456K. The position accounts for ﹤0.01% of the portfolio, ranked #748.

Aviva first reported a position in MDXG in Q1 2024 and has held it in 10 quarters since. The position peaked at $629K in Q4 2024. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

Aviva held 118,456 shares of MiMedx Group worth $456K as of Q2 2026.
Aviva bought 22,965 MiMedx Group shares in Q2 2026, an estimated $83.8K.
MiMedx Group made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #748 holding.
Aviva first reported a position in MiMedx Group in Q1 2024 and has held it in 10 quarters since.
Aviva's MiMedx Group position peaked at $629K in Q4 2024.
226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.